全球動脈粥狀硬化斑塊切除術設備市場規模、佔有率和成長分析：按產品、按應用、按最終用戶、按地區 - 產業預測 (2024-2031)

2022年全球動脈粥狀硬化斑塊切除術設備市場規模約為8.903億美元，由2023年的9.6241億美元成長，預計2031年將達到17.946億美元，預測期內（2024-2031年）年複合成長率為8.1%。

全球動脈粥狀硬化斑塊切除術設備市場預計將大幅成長，主要是由於老年人口增加、不良生活習慣和不健康飲食習慣導致心血管疾病發生率不斷上升。隨著越來越多的患者尋求有效的治療方法，這些日益嚴重的健康問題預計將推動對動脈粥狀硬化斑塊切除術設備的需求。此外，微創手術的趨勢獲得關注，為動脈粥狀硬化斑塊切除術設備提供者提供了新的途徑，因為醫療專業人員和患者都青睞心血管干預的微創選擇。此外，對醫學研發的持續投資預計將推動動脈粥狀硬化斑塊切除術設備的技術進步，並在該領域創造更多商機。然而，它面臨著諸如與動脈粥狀硬化斑塊切除術術和設備相關的高成本、手術期間併發症的潛在風險以及替代治療方案的可用性等挑戰，這可能會阻礙市場的長期擴張。也就是說，不斷成長的需求、技術創新以及對微創解決方案不斷變化的偏好相結合，可能會使動脈粥狀硬化斑塊切除術設備供應商在未來幾年從這個不斷成長的市場中獲利。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二級/一級資訊來源
• 市場規模估算
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 課題
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 創新矩陣
• 技術分析
• 監管分析
• 專利分析
• 市場生態系統

動脈粥狀硬化斑塊切除術設備市場：依產品

• 市場概況
• 定向動脈粥狀硬化斑塊切除術系統
• 旋磨動脈粥狀硬化斑塊切除術系統
• 光學消融（雷射）動脈粥狀硬化斑塊切除術系統
• 旋切動脈粥狀硬化斑塊切除術系統
• 支援設備
• 其他

動脈粥狀硬化斑塊切除術設備市場：依應用分類

• 市場概況
• 周圍血管
• 心血管
• 神經血管

動脈粥狀硬化斑塊切除術設備市場：依最終用戶分類

• 市場概況
• 醫院和外科中心
• 門診治療中心
• 實驗室和學術機構
• 其他

動脈粥狀硬化斑塊切除術設備市場：依地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Medtronic Plc（Ireland）
• Boston Scientific Corporation（USA）
• Cardiovascular Systems, Inc.（USA）
• Royal Philips（Netherlands）
• Avinger, Inc.（USA）
• Terumo Corporation（Japan）
• AngioDynamics, Inc.（USA）
• Braun Group（Germany）
• Abbott Laboratories（USA）
• B. Braun Melsungen AG（Germany）
• Biotronik SE & Co. KG（Germany）
• Biomerics（USA）
• Philips（Netherlands）
• Cook Medical, Inc.（USA）
• Cardinal Health, Inc.（USA）
• Rex Medical, LP（USA）
• WL Gore & Associates, Inc.（USA）
• Minnetronix, Inc.（USA）
• Merit Medical Systems, Inc.（USA）
• NexStep Medical（USA）

Global Atherectomy Devices Market size was valued at around USD 890.30 million in 2022 and is expected to rise from USD 962.41 million in 2023 to reach a value of USD 1794.60 million by 2031, at a CAGR of 8.1% over the forecast period (2024-2031).

The global market for atherectomy devices is poised for significant growth, driven largely by the escalating incidence of cardiovascular diseases, which are increasingly prevalent due to a growing elderly population, poor lifestyle choices, and unhealthy dietary habits. This rising health concern is expected to bolster the demand for atherectomy devices as more patients seek effective treatment options. Additionally, the trend towards minimally invasive procedures is gaining traction, presenting new avenues for providers of atherectomy devices as healthcare professionals and patients alike favor less invasive options for cardiovascular interventions. Furthermore, ongoing investments in medical research and development are anticipated to propel technological advancements in atherectomy devices, creating even more opportunities in this sector. However, the market faces challenges, including the high costs associated with atherectomy procedures and devices, potential risks of complications during operations, and the availability of alternative treatment options, which may hinder market expansion in the long term. Nonetheless, the confluence of increasing demand, technological innovations, and a shifting preference towards minimally invasive solutions positions atherectomy device providers to capitalize on this growing market in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Atherectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Atherectomy Devices Market Segmental Analysis

Global Atherectomy Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Support Devices, and Others. Based on Application, the market is segmented into Peripheral Vascular, Cardiovascular, and Neurovascular. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Atherectomy Devices Market

The global atherectomy devices market is significantly driven by the aging population, which is increasingly at risk for cardiovascular complications like arterial blockages. As older individuals often experience a higher prevalence of such conditions, the demand for effective treatment options is rising. Atherectomy devices, essential for addressing these disorders, are gaining traction due to a growing preference for minimally invasive procedures among geriatric patients. This trend not only enhances patient outcomes but also aligns with the broader shift towards less invasive, safer medical interventions, thereby propelling the market's expansion and adoption in cardiovascular care strategies worldwide.

Restraints in the Global Atherectomy Devices Market

One of the significant market restraints for the global atherectomy devices market is the inherent risk of complications associated with atherectomy procedures. The complexity of these procedures, influenced by numerous variables such as patient anatomy, operator skill, and device selection, presents challenges in ensuring optimal outcomes. The fear of potential complications, including vessel perforation, dissection, or embolization, can deter both healthcare providers and patients from opting for atherectomy as a treatment option. Consequently, the apprehension surrounding these risks may hinder the growth of atherectomy device sales, as medical professionals may seek alternative treatment modalities perceived as less risky.

Market Trends of the Global Atherectomy Devices Market

The Global Atherectomy Devices market is witnessing a notable trend towards the integration of advanced technologies, particularly artificial intelligence (AI) and machine learning (ML). Manufacturers are increasingly focusing on these innovations to enhance the functionality and precision of their devices, ultimately improving patient outcomes in vascular interventions. By harnessing AI and ML, companies can streamline both the development processes and clinical deployment of atherectomy systems, thereby maximizing their operational efficiency and market reach. This technological shift is expected to drive competitive advantage in the marketplace, positioning manufacturers at the forefront of the evolving landscape of cardiovascular treatment solutions.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Innovation Matrix
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Ecosystem of the Market

Global Atherectomy Devices Market, By Product

• Market Overview
• Directional Atherectomy Systems
• Orbital Atherectomy Systems
• Photo-Ablative (Laser) Atherectomy Systems
• Rotational Atherectomy Systems
• Support Devices
• Others

Global Atherectomy Devices Market, By Application

• Market Overview
• Peripheral Vascular Applications
• Cardiovascular Applications
• Neurovascular Applications

Global Atherectomy Devices Market, By End User

• Market Overview
• Hospitals & Surgical Centers
• Ambulatory Care Centers
• Research Laboratories & Academic Institutes
• Others

Atherectomy Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiovascular Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avinger, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rex Medical, L.P. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Minnetronix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NexStep Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments